Symbol | Exchange | Currency |
|---|
28-day survival will be evaluated in ARDS patients hospitalized with Covid-19Updated protocol approved by study's ethics committeeCompany exploring pathways for treating general...
Investing.com - Edesa Biotech (NASDAQ: EDSA) reported first quarter EPS of $-0.170, $0.02 better than the analyst estimate of $-0.190. Revenue for the quarter came in at $0.00...
Investing.com - Edesa Biotech (NASDAQ: EDSA) reported first quarter EPS of $-0.395, in line with the analyst estimate of $-0.395. Revenue for the quarter came in at $0.00 versus...
Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on inflammatory and immune-related diseases. The Company's two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy, developing as a treatment for acute respiratory distress syndrome (ARDS), a life-threatening form of respiratory failure. ARDS can be caused by viral diseases, including Covid-19, bacterial pneumonia, sepsis, chest injury and other causes. Specifically, EB05 inhibits toll-like receptor 4 (TLR4), an immune signaling protein and an important mediator of inflammation that has been shown to be activated by SARS-COV2 as well as other respiratory infections, such as influenza. In addition to EB05, the Company is also developing an sPLA2 inhibitor, designated as EB01, as a topical treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Buy | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 205.86 | 205.86 | 197.23 | +10.58 | +5.42% | 87.25M | NASDAQ | |||
| 163.78 | 163.91 | 162.13 | +1.42 | +0.87% | 21.12M | NASDAQ | |||
| 62.19 | 62.25 | 61.96 | +0.34 | +0.54% | 3.69M | NYSE | |||
| 209.84 | 210.54 | 206.77 | +2.01 | +0.96% | 12.29M | NASDAQ | |||
| 102.48 | 103.25 | 101.05 | +1.60 | +1.58% | 13.85M | NASDAQ | |||
| 285.84 | 285.86 | 283.03 | +1.79 | +0.63% | 11.36M | NASDAQ | |||
| 40.34 | 40.60 | 40.31 | -0.04 | -0.09% | 5.29M | NYSE | |||
| 97.46 | 97.72 | 95.27 | -0.42 | -0.43% | 32.11M | NASDAQ | |||
| 103.16 | 103.29 | 101.95 | +1.16 | +1.14% | 22.77M | NASDAQ | |||
| 166.31 | 166.68 | 164.29 | +3.64 | +2.24% | 458.11K | NASDAQ | |||
| 277.24 | 277.49 | 271.05 | +3.40 | +1.24% | 21.89M | NASDAQ | |||
| 8.44 | 8.47 | 8.09 | +0.28 | +3.50% | 12.74M | NYSE | |||
| 102.89 | 103.63 | 101.44 | +1.57 | +1.55% | 11.03M | NASDAQ | |||
| 47.72 | 47.85 | 45.95 | +1.21 | +2.60% | 7.35M | NYSE | |||
| 10.27 | 10.275 | 10.27 | 0.00 | 0.00% | 0.00 | NYSE |